A Viral Phospholipase A2 Is Required for Parvovirus Infectivity

Developmental Cell

Volumn 1, Issue 2, 2001, Pages 291-302

  Zádori, Zoltán ^a   Szelei, József ^a   Lacoste, Marie Claude ^a   Li, Yi ^a   Gariépy, Sébastien ^a   Raymond, Philippe ^a   Allaire, Marc ^a   Nabi, Ivan R ^b   Tijssen, Peter ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DENSOVIRUS; GALLERIA MELLONELLA; INSECTA; MIRIDAE; PARVOVIRUS; PORCINE PARVOVIRUS; SUIDAE;

CALCIUM; DNA; PHOSPHOLIPASE A; THIOREDOXIN;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGICAL MODEL; CELL NUCLEUS; CHEMICAL STRUCTURE; ENDOSOME; ENZYMOLOGY; FLUORESCENCE MICROSCOPY; GENE VECTOR; GENETIC TRANSFECTION; IN SITU HYBRIDIZATION; LYSOSOME; METABOLISM; MOLECULAR GENETICS; MUTATION; PARVOVIRUS; PHYSIOLOGY; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; THIN LAYER CHROMATOGRAPHY; VIRUS CAPSID;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; CALCIUM; CAPSID; CELL NUCLEUS; CHROMATOGRAPHY, THIN LAYER; DNA; ENDOSOMES; GENETIC VECTORS; IN SITU HYBRIDIZATION; LYSOSOMES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PARVOVIRUS; PHOSPHOLIPASES A; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; THIOREDOXIN; TRANSFECTION;

EID: 0035431876     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-5807(01)00031-4     Document Type: Article

References (57)

1. Balsinde, J., Balboa, M.A., Insel, P.A., and Dennis, E.A. (1999). Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 39, 175-189.
2. Bergeron, J., Menezes, J., and Tijssen, P. (1993). Genomic organization and mapping of transcription and translation products of the NADL-2 strain of porcine parvovirus. Virology 197, 86-98.
3. Bergeron, J., Hebert, B., and Tijssen, P. (1996). Genome organization of the Kresse strain of porcine parvovirus: identification of the allotropic determinant and comparison with those of NADL-2 and field isolates. J. Virol. 70, 2508-2515.
4. Berns, K.I. (1996). Parvoviridae: the viruses and their replication. In Fundamental Virology, Third Edition, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Philadelphia, PA: Lippincott-Raven), pp. 1017-1041.
5. Brown, K.E. (2000). Haematological consequences of parvovirus B19 infection. Baillieres Best Pract. Res. Clin. Haematol. 13, 245-259.
6. Brown, K.E., Anderson, S.M., and Young, N.S. (1993). Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262, 114-117.
7. Chapman, M.S., and Rossmann, M.G. (1993). Structure, sequence and function correlations among parvoviruses. Virology 194, 491-508.
8. Cotmore, S.F., D'Abramo, M.A., Jr., Ticknor, C.M., and Tattersall, P. (1999). Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly. Virology 254, 169-181.
9. Dennis, E.A. (1997). The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22, 1-2.
10. Dessen, A. (2000). Phospholipase A(2) enzymes: structural diversity in lipid messenger metabolism. Structure 8, R15-R22.
11. Dijkstra, B.W., Drenth, J., and Kalk, K.H. (1981). Active site and catalytic mechanism of phospholipase A2. Nature 289, 604-606.
12. Douar, A.M., Poulard, K., Stockholm, D., and Danos, O. (2001). Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75, 1824-1833.
13. Duan, D., Li, Q., Kao, A.W., Yue, Y., Pessin, J.E., and Engelhardt, J.F. (1999). Dynamin is required for recombinant adeno-associated virus type 2 infection. J. Virol. 73, 10371-10376.
14. Elsbach, P., and Weiss, J. (1991). Utilization of labeled Escherichia coli as phospholipase substrate. Methods Enzymol. 197, 24-31.
15. Foto, F., Saag, K.G., Scharosch, L.L., Howard, E.J., and Naides, S.J. (1993). Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J. Infect. Dis. 167, 744-748.
16. Gardiner, E.M., and Tattersall, P. (1988). Evidence that developmentally regulated control of gene expression by a parvoviral allotropic determinant is particle mediated. J. Virol. 62, 1713-1722.
17. 2: more than electrostatics and a major role for tryptophan. Curr. Opin. Struct. Biol. 9, 428-432.
18. Geuze, H.J., Stoorvogel, W., Strous, G.J., Slot, J.W., Bleekemolen, J.E., and Mellman, I. (1988). Sorting of mannose-6-phosphate receptors and lysosomal membrane proteins in endocytic vesicles. J. Cell Biol. 107, 2491-2501.
19. Griffiths, G., Hoflack, B., Simons, K., Mellman, I., and Kornfeld, S. (1988). The mannose-6-phosphate receptor and the biogenesis of lysosomes. Cell 52, 329-341.
20. Haberhausen, G., Pinsl, J., Kuhn, C.C., and Markert-Hahn, C. (1998). Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays. J. Clin. Microbiol. 36, 628-633.
21. 2. J. Biol. Chem. 271, 11881-11888.
22. Hansen, J., Qing, K., and Srivastava, A. (2001). Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J. Virol. 75, 4080-4090.
23. Hariri, M., Millane, G., Guimond, M.-P., Guay, G., Dennis, J.W., and Nabi, I.R. (2000). Biogenesis of multilamellar bodies via autophagy. Mol. Biol. Cell 11, 255-268.
24. Hermonat, P.L., Labow, M.A., Wright, R., Berns, K.I., and Muzyczka, N. (1984). Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J. Virol. 51, 329-339.
25. Kasamatsu, H., and Nakanishi, A. (1998). How do animal DNA viruses get to the nucleus? Annu. Rev. Microbiol. 52, 627-686.
26. 2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett. 410, 49-53.
27. Loizou, S., Cazabon, J.K., Walport, M.J., Tait, D., and So, A.K. (1997). Similarities of specificity and cofactor dependence in serum anti-phospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 40, 103-108.
28. Manjunath, P., Soubeyrand, S., Chandonnet, L., and Roberts, K.D. (1994). Major proteins of bovine seminal plasma inhibit phospholipase A2. Biochem. J. 303, 121-128.
29. Moore, T.L. (2000). Parvovirus-associated arthritis. Curr. Opin. Rheumatol. 12, 289-294.
30. 2. Crit. Rev. Immunol. 17, 225-283.
31. Nabi, I.R., and Rodriguez-Boulan, E. (1993). Increased LAMP-2 polylactosamine glycosylation is associated with its slower Golgi transit during establishment of a polarized MDCK epithelial monolayer. Mol. Biol. Cell 4, 627-635.
32. Nabi, I.R., Le Bivic, A., Fambrough, D., and Rodriguez-Boulan, E. (1991). An endogenous MDCK lysosomal membrane glycoprotein is targeted basolaterally before delivery to lysosomes. J. Cell Biol. 115, 1573-1584.
33. Parker, J.S., and Parrish, C.R. (1997). Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid. J. Virol. 71, 9214-9222.
34. Parker, J.S., and Parrish, C.R. (2000). Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated chlatrin-mediated endocytosis, followed by slower intracellular trafficking. J. Virol. 74, 1919-1930.
35. Parker, J.S., Murphy, W.J., Wang, D., O'Brien, S.J., and Parrish, C.R. (2001). Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J. Virol. 75, 3896-3902.
36. Parrish, C.R. (1999). Host range relationships and the evolution of canine parvovirus. Vet. Microbiol. 69, 29-40.
37. Previsani, N., Fontana, S., Hirt, B., and Beard, P. (1997). Growth of the parvovirus minute virus of mice MVMp3 in EL4 lymphocytes is restricted after cell entry and before viral DNA amplification: cell-specific differences in virus uncoating in vitro. J. Virol. 71, 7769-7780.
38. Pruzanski, W., and Vadas, P. (1991). Phospholipase A2 - a mediator between proximal and distal effectors of inflammation. Immunol. Today 12, 143-146.
39. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., and Srivastava, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5, 71-77.
40. Renetseder, R., Brunie, S., Dijkstra, B.W., Drenth, J., and Sigler, P.B. (1985). A comparison of the crystal structures of phospholipase A2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260, 11627-11634.
41. Rosenfeld, S.J., Yoshimoto, K., Kajigaya, S., Anderson, S., Young, N.S., Field, A., Warrener, P., Bansal, G., and Collett, M.S. (1992). Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J. Clin. Invest. 89, 2023-2029. Erratum. J. Clin. Invest. 90, 2609.
42. Sanlioglu, S., Benson, P.K., Yang, J., Atkinson, E.M., Reynolds, T., and Engelhardt, J.F. (2000). Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by racl and phosphatidylinositol-3 kinase activation. J. Virol. 74, 9184-9196.
43. Sekar, K., and Sundaralingam, M. (1999). High-resolution refinement of orthorhombic bovine pancreatic phospholipase A2. Acta Crystallogr. D Biol. Crystallogr. 55, 46-50.
44. Simpson, A.A., Chipman, P.R., Baker, T.S., Tijssen, P., and Rossmann, M.G. (1998). The structure of an insect parvovirus (Galleria mellonella densovirus) at 3.7 A resolution. Structure 6, 1355-1367.
45. Sperinde, G.V., and Nugent, M.A. (1998). Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells. Biochemistry. 37, 13153-13164.
46. Summerford, C., Bartlett, J.S., and Samulski, R.J. (1999). αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78-82.
47. Takahashi, Y., Murai, C., Ishii, K., Sugamura, K., and Sasaki, T. (1998a). Human parvovirus B19 in rheumatoid arthritis. Int. Rev. Immunol. 17, 309-321.
48. Takahashi, Y., Murai, C., Shibata, S., Munakata, Y., Ishii, K., Saitoh, T., Sawai, T., Sugamura, K., and Sasaki, T. (1998b). Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 95, 8227-8232.
49. Tattersall, P., and Cotmore, S.F. (1990). Reproduction of autonomous parvovirus DNA. In Handbook of Parvoviruses, Vol. 1, P. Tijssen, ed. (Boca Raton, FL: CRC Press), pp. 123-140.
50. Tijssen, P., and Bergoin, M. (1995). Densonucleosis viruses constitute an increasingly diversified subfamily among the parvoviruses. Sem. Virol. 6, 347-355.
51. Tullis, G.E., Burger, L.R., and Pintel, D.J. (1993). The minor capsid protein VP1 of the autonomous parvovirus minute virus of mice is dispensable for encapsidation of progeny single-stranded DNA but is required for infectivity. J. Virol. 67, 131-141.
52. Vihinen-Ranta, M., Kalela, A., Makinen, P., Kakkola, L., Marjomaki, V., and Vuento, M. (1998). Intracellular route of canine parvovirus entry. J. Virol. 72, 802-806.
53. Vihinen-Ranta, M., Yuan, W., and Parrish, C.R. (2000). Cytoplasmic trafficking of canine parvovirus capsid and its role in infection and nuclear transport. J. Virol. 74, 4853-4859.
54. Weiner, M.P., Costa, G.L., Schoettlin, W., Cline, J., Mathur, E., and Bauer, J.C. (1994). Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction. Gene 151, 119-123.
55. Willwand, K., and Kaaden, O.R. (1988). Capsid protein (p85) of Aleutian disease virus is a major DNA-binding protein. Virology 166, 52-57.
56. Ytterberg, S.R. (1999). Viral arthritis. Curr. Opin. Rheumatol. 11, 275-280.
57. Zhu, H., Dupureur, C.M., Zhang, X., and Tsai, M.D. (1995). Phospholipase A2 engineering. The roles of disulfide bonds in structure, conformational stability, and catalytic function. Biochemistry 34, 15307-15314.